categories
HOT TOPICS
- The Accelerator Conundrum
- The Startup Velocity Question
- Platform as a Service
- Man and Superman
- Web 3.0 = (4C + P + VS)
- The Future: End of Capitalism
- Capitalism 2.0
healthcare
1Mby1M Virtual Accelerator Investor Forum: With Darshana Zaveri of Catalyst Health Ventures (Part 4)
Sramana Mitra: Given that you are in a sector that is very relevant to what we are going through right now, what do you see is going to happen? There is a furious effort to come up with all kinds of testing devices with coronavirus and testing for antibodies of who has already gotten it.
1Mby1M Virtual Accelerator Investor Forum: With Darshana Zaveri of Catalyst Health Ventures (Part 3)
Sramana Mitra: What is the go-to market strategy for this company? What is your investment thesis around go-to market strategies? You mentioned early on that these companies don’t necessarily go to market on their own. Darshana Zaveri: This company did exit. It was bought out in 2018 by Boston Scientific. We did the seed round
Thought Leaders in Artificial Intelligence: Matthew Sappern, CEO of PeriGen (Part 5)
Matthew Sappern: There are a lot of people who feel that artificial intelligence and machine learning is much further along than it really is. There is so much data out there right now. I think that’s an important first step. There’s data and there’s actionable data or what some of my colleagues call the ground
Thought Leaders in Artificial Intelligence: Matthew Sappern, CEO of PeriGen (Part 4)
Sramana Mitra: We’re seeing an increasing amount of AI applications in the healthcare IT domain. I don’t know if you’re familiar with this announcement that we recently made of a European partnership with the European Institute of Innovation and Technology and their digital health arm. 115 companies from Europe are going to be accelerated within the
Thought Leaders in Artificial Intelligence: Matthew Sappern, CEO of PeriGen (Part 3)
Sramana Mitra: In the healthcare space, where are some of the other areas where you see the possibilities of this kind of pattern recognition and interventions based on pattern recognition? Matthew Sappern: There are so many. Take the ICU for instance. You walk into an ICU. A typical patient has multiple telemetry devices hooked up.
Thought Leaders in Artificial Intelligence: Matthew Sappern, CEO of PeriGen (Part 2)
Matthew Sappern: Where computers are so helpful with that, as you can imagine, is computers don’t get tired. They’re not getting coffee or arguing with someone. They look at the same series of data the same way every time. Once we figured out the ability to interpret these waves, we’re able to let the doctors
Thought Leaders in Artificial Intelligence: Matthew Sappern, CEO of PeriGen (Part 1)
I have been talking about the applications of AI on Healthcare IT problems. Here is a great case study. Sramana Mitra: Let’s start by having you introduce yourself as well as PeriGen to our audience. Matthew Sappern: I’m the CEO of of PeriGen. PeriGen is a software developer. We make software as a medical device.
Capital Efficient Entrepreneurship: Philippe d’Offay, CEO of PMD (Part 4)
Sramana Mitra: What was the journey like in 2001 to 2007? It was slow as you are pointing out, but were you still getting customers? What was the sustaining strategy during that period? Philippe d’Offay: At that time in healthcare, the consolidation hadn’t quite begun. There was this very strong entrepreneurial spirit in healthcare. We were
